Casale Maddalena, Baldini Marina Itala, Del Monte Patrizia, Gigante Antonia, Grandone Anna, Origa Raffaella, Poggi Maurizio, Gadda Franco, Lai Rosalba, Marchetti Monia, Forni Gian Luca
Dipartimento della Donna, del Bambino e di Chirurgia Generale e Specialistica, Università degli Studi della Campania Luigi Vanvitelli, 80138 Naples, Italy.
Centro Malattie Rare, UOC Medicina Interna, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, 20122 Milan, Italy.
J Clin Med. 2022 Mar 25;11(7):1826. doi: 10.3390/jcm11071826.
The treatment of endocrinopathies in haemoglobinopathies is a continually expanding research area; therefore, recommendations supporting the appropriateness of treatments are a pressing need for the medical community.
The Management Committee of SITE selected and gathered a multidisciplinary and multi-professional team, including experts in haemoglobinopathies and experts in endocrinopathies, who have been flanked by experts with methodological and organizational expertise, in order to formulate recommendations based on the available scientific evidence integrated by personal clinical experience. The project followed the systematic approach for the production of clinical practice guidelines according to the methodology suggested by the National Center for Clinical Excellence, Quality and Safety of Care (CNEC).
Out of 14 topics, 100 clinical questions were addressed, and 206 recommendations were elaborated on. The strength of recommendations, panel agreement, a short general description of the topic, and the interpretation of evidence were reported.
Good Practice Recommendations are the final outcome of translational research and allow one to transfer to the daily clinical practice of endocrine complications in haemoglobinopathies.
血红蛋白病内分泌病变的治疗是一个不断扩展的研究领域;因此,为医学界提供支持治疗适宜性的建议迫在眉睫。
SITE管理委员会挑选并组建了一个多学科、多专业的团队,包括血红蛋白病专家和内分泌病变专家,并辅以方法学和组织方面的专家,以便根据现有科学证据并结合个人临床经验制定建议。该项目遵循了国家临床卓越、质量与安全中心(CNEC)建议的方法学,采用系统方法制定临床实践指南。
针对14个主题提出了100个临床问题,并阐述了206条建议。报告了建议的强度、专家小组的一致性、主题的简短概述以及证据解读。
良好实践建议是转化研究的最终成果,有助于将其应用于血红蛋白病内分泌并发症的日常临床实践。